GCISX
Price
$20.04
Change
+$0.08 (+0.40%)
Updated
Jun 2 closing price
Net Assets
6.67B
MDIHX
Price
$29.88
Change
+$0.19 (+0.64%)
Updated
Jun 2 closing price
Net Assets
44.56B
Interact to see
Advertisement

GCISX vs MDIHX

Header iconGCISX vs MDIHX Comparison
Open Charts GCISX vs MDIHXBanner chart's image
GCISX vs MDIHX Comparison Chart in %
View a ticker or compare two or three
VS
GCISX vs. MDIHX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCISX is a Buy and MDIHX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MDIHX has more cash in the bank: 44.6B vs. GCISX (6.67B). MDIHX pays higher dividends than GCISX: MDIHX (1.85) vs GCISX (1.06). GCISX was incepted earlier than MDIHX: GCISX (29 years) vs MDIHX (21 years). GCISX (1.37) is less costly to investors than MDIHX (1.10). GCISX is a more actively managed with annual turnover of: 156.00 vs. MDIHX (2.00). GCISX (0) and MDIHX (0) have matching initial minimum investment requirements. GCISX annual gain was more profitable for investors over the last year : 21.12 vs. MDIHX (17.73). GCISX return over 5 years is better than : 48.30 vs. MDIHX (27.94).
GCISXMDIHXGCISX / MDIHX
Total Expense Ratio1.321.08122%
Annual Report Gross Expense Ratio1.371.10125%
Fund Existence29 years21 years-
Gain YTD11.9469.436127%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets6.67B44.6B15%
Annual Yield % from dividends1.061.8557%
Returns for 1 year21.1217.73119%
Returns for 3 years66.1246.99141%
Returns for 5 years48.3027.94173%
Returns for 10 years130.12123.06106%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATNM1.220.04
+3.39%
Actinium Pharmaceuticals
QMMM119.40N/A
N/A
QMMM Holdings Ltd
KMPR24.25-0.80
-3.19%
Kemper Corp
DELL435.31-30.65
-6.58%
Dell Technologies
TENX10.95-1.02
-8.52%
Tenax Therapeutics